🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The COR-INSIGHT trial aims to evaluate the effectiveness of Peerbridge COR ...
Status
Enrolling By Invitation
Location
Peerbridge Health, Melbourne, Florida 32935
Start Date
2024-11-16
Trial ID
NCT06763549
The purpose of this platform study is to evaluate the safety, tolerability,...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-01-18
Trial ID
NCT06162221
Treatments Being Tested
This phase II MATCH treatment trial tests how well palbociclib (PD-0332991)...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2017-03-22
Trial ID
NCT06390839
The purpose of this platform study is to evaluate the safety, tolerability,...
Status
Recruiting
Location
Ironwood Cancer and Research Centers
Start Date
2024-05-24
Trial ID
NCT06445062
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
This phase II MATCH treatment trial tests how well nivolumab and BMS-986016...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-02-22
Trial ID
NCT06400264
This phase II Pediatric MATCH screening and multi-sub-trial studies how wel...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-07-31
Trial ID
NCT03155620
Treatments Being Tested
HEM-iSMART is a master protocol which investigates multiple investigational...
Status
Recruiting
Location
St. Anna Kinderspital
Start Date
2023-11-14
Trial ID
NCT05658640
Treatments Being Tested
The objective of this Master Protocol is to evaluate the efficacy and safet...
Status
Recruiting
Location
Precision NextGen Oncology & Research Center
Start Date
2023-02-21
Trial ID
NCT05503797
Treatments Being Tested
This phase II MATCH treatment trial identifies the effects of GDC-0032 (tas...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2016-02-25
Trial ID
NCT04439175
Treatments Being Tested